Karyopharm Therapeutics Inc (FRA:25K)
€ 0.5734 -0.0194 (-3.27%) Market Cap: 84.88 Mil Enterprise Value: 143.15 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 64/100

Q1 2020 Karyopharm Therapeutics Inc Earnings Call Transcript

May 05, 2020 / 12:30PM GMT
Release Date Price: €18.9 (+8.00%)
Operator

Good morning. My name is Patrice, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics First Quarter 2020 Financial Results Conference Call. (Operator Instructions) Please be advised that this call is being recorded at the company's request.

I would now like to turn the call over to Mr. Ian Karp, Karyopharm's Vice President, Investor and Public Relations.

Ian Karp
Karyopharm Therapeutics Inc. - VP of Investor & Public Relations

Thank you, Patrice, and thank you all for joining us on today's conference call to discuss Karyopharm's first quarter 2020 financial results and business update. This is Ian Karp, and I'm joined today by Dr. Michael Kauffman, Chief Executive Officer; Dr. Sharon Shacham, President and Chief Scientific Officer; Mr. Mike Mason, Chief Financial Officer; Mr. John Demaree, Chief Commercial Officer; Mr. Christopher Primiano, Chief Business Officer and General Counsel; Dr. Jatin Shah, Chief Medical Officer; and Mr. Perry Monaco, Senior Vice President of Sales.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot